Novo Nordisk to invest $1.2B in new bio-manufacturing operations in Clayton, North Carolina

Novo Nordisk will invest $1.2 billion to build new bio-manufacturing operations at its Clayton, North Carolina campus to produce the active ingredient for its insulin products. The project will create 691 jobs.

“This billion-dollar decision by Novo Nordisk more than doubles the size of its North Carolina workforce and underscores the Research Triangle's global leadership in bio-manufacturing.”growwithjoco.com

• 1 source
• growwithjoco.comNovo Nordisk To Add Major New Bio-Manufacturing Operations In Clayton | Johnston County Economic DevelopmentJan 11, 2019

Summarized from public sources; check the original articles before acting on it.